Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
We report a case of a 20 years female referred to us with a history of a brief psychotic episode for which she was given inj. Haloperidol. The patient presented in an unconscious state with high grade fever. The diagnosis was kept as neuroleptic malignant syndrome after ruling out other possibilities. The patient did not respond to Bromocriptine and Dantrolene. With the recent evidence of electroconvulsive therapy being useful in these patients, we went ahead with the same. We present this case to share our experience of the excellent response of neuroleptic malignant syndrome to electroconvulsive therapy.
Patel
A L
AL
Department of General Medicine, Grant Medical College and Sir J. J. Group of Hospitals, Mumbai, India.
Shaikh
W A
WA
Khobragade
A K
AK
Soni
H G
HG
Joshi
A S
AS
Sahastrabuddhe
G S
GS
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D003620:Dantrolene / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D016896:Treatment Outcome
D018491:Dopamine Agonists; D009125:Muscle Relaxants, Central; D001971:Bromocriptine; D003620:Dantrolene